<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20131022015111N3</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2018-02-18</date_registration>
      <primary_sponsor>Kermanshah University of Medical Sciences</primary_sponsor>
      <public_title>Effect of probiotic yogurt fortified with vitamin D on fatty liver</public_title>
      <acronym></acronym>
      <scientific_title>Effects of probiotic yogurt fortified with vitamin D in comparison to conventional yogurt on hepatic enzymes, lipid profile, glycemic and anthropometric indices in patients with non-alcoholic fatty liver disease</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2017-10-23</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>90</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/28809</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Triple blinded, Placebo: Used, Assignment: Parallel, Purpose: Treatment, Randomization description: Individual Randomization - Using Random Number Tables, Blinding description: - The appearance of yogurt is the same for both participants in both groups.
- Ultrasound specialist will not be aware of the group of individuals.
- The main investigator will not be aware of the content of yogurts and also of the group which they are in.
- The staff of collecting information, the yogurt providers and also description providers will also be unaware of the content of yogurt and the group of participants.
- persons who analyzing data will be unaware of the kind of group which each person belong.</study_design>
      <phase>3</phase>
      <hc_freetext>fatty liver.</hc_freetext>
      <i_freetext>Intervention 1: Intervention group: Riched yogurt (100 cc/day) with 1000 IU vitamin D and 40000000 cfu Probiotic. Intervention 2: Control group: Plain yogurt (100 cc/day) receiving group.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>No - There is not a plan to make this available</results_IPD_plan>
      <results_IPD_description>Justification or reason for not sharing IPD is Trials that began to sample collection on January 11, 2018 should have a release plan when registering their study protocol</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Mojgan Morvaridzadeh</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Nutrition and Food Sciences Faculty, Next to the Farabi Hospital, Dolat Abad Blvd, Isar Square, Imam Hosein Exp,</address>
        <city>Kermanshah</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>6719851351</zip>
        <telephone>+98 83 3723 3221</telephone>
        <email>morvaridzadehm@yahoo.com</email>
        <affiliation>Kermanshah University of Medical Sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Seyed Mostafa Nachvak</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Nutrition and Food Sciences Faculty, Next to the Farabi Hospital, Dolat Abad Blvd, Isar Square, Imam Hosein Exp,</address>
        <city>Kermanshah</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>6719851351</zip>
        <telephone>+98 83388264165</telephone>
        <email>Smnachvak@hotmail.com</email>
        <affiliation>Kermanshah University of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>individuals with new diagnosed fatty liver disease
individuals with grade 1 or 2 fatty liver disease
individuals with the age of 25 to 55 years old
individuals who have full satisfaction to participate</inclusion_criteria>
      <agemin>25 years</agemin>
      <agemax>55 years</agemax>
      <gender>Both</gender>
      <exclusion_criteria>individuals who use any kind of drug
individuals who has allergic to yogurt
individuals who are suffering from other chronic diseases like: cardio vascular diseases, kidney diseases, thyroid and...
individuals who are suffering from other chronic diseases like: any kind of hepatitis, cirrhosis and ... or had liver transplant.
individuals who had a background of cancer
women who use contraceptive drugs
individuals who use certain regimens or weight loss regimens.
individuals who use any vitamin supplements
individuals who use any kind of probiotic supplement or probiotic food products
individuals who take any antioxidant supplements
individuals who have taken any type of fiber supplement or omega-3 supplement during 6 weeks before starting the study.
individuals who have taken antibiotics over the 2 weeks before starting the study.
Women who are pregnant, lactating or menopause.
individuals who use cigarettes and alcohol.</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>K76.0</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>Fatty (change of) liver, not elsewhere classified</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Treatment - Other</i_code>
      <i_code>Placebo</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention group: Riched yogurt (100 cc/day) with 1000 IU vitamin D and 40000000 cfu Probiotic</i_keyword>
      <i_keyword>Control group: Plain yogurt (100 cc/day) receiving group</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Alanine Aminotransferase. Timepoint: Before and 3 month after intervention. Method of measurement: by using Kit.</prim_outcome>
      <prim_outcome>Aspartate Aminotransferase. Timepoint: Before and 3 month after intervention. Method of measurement: by using Kit.</prim_outcome>
      <prim_outcome>Total Cholesterol. Timepoint: Before and 3 month after intervention. Method of measurement: By using Kit.</prim_outcome>
      <prim_outcome>Trigliceride. Timepoint: Before and 3 month after intervention. Method of measurement: By using Kit.</prim_outcome>
      <prim_outcome>Low-density lipoprotein. Timepoint: Before and 3 month after intervention. Method of measurement: By using Kit.</prim_outcome>
      <prim_outcome>High-density lipoprotein. Timepoint: Before and 3 month after intervention. Method of measurement: By using Kit.</prim_outcome>
      <prim_outcome>Fast Blood Sugar. Timepoint: Before and 3 month after intervention. Method of measurement: By using Kit.</prim_outcome>
      <prim_outcome>Serum Insulin. Timepoint: Before and 3 month after intervention. Method of measurement: Insulin MONOBIND Kit.</prim_outcome>
      <prim_outcome>Weight. Timepoint: Before and 3 month after intervention. Method of measurement: scale.</prim_outcome>
      <prim_outcome>Abdomen Circumference. Timepoint: Before and 3 month after intervention. Method of measurement: Tape measure.</prim_outcome>
      <prim_outcome>Hip Circumference. Timepoint: Before and 3 month after intervention. Method of measurement: Tape measure.</prim_outcome>
      <prim_outcome>Body Fat Percentage. Timepoint: Before and 3 month after intervention. Method of measurement: Body Analyzer Machine.</prim_outcome>
      <prim_outcome>Body Muscle Percentage. Timepoint: Before and 3 month after intervention. Method of measurement: Body Analyzer Machine.</prim_outcome>
      <prim_outcome>Vitamin D. Timepoint: Before and 3 month after intervention. Method of measurement: By using Kit.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome></sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Kermanshah University of Medical Sciences</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2018-01-03</approval_date>
        <contact_name>Ethics Committee of Kermanshah University of Medical Sciences</contact_name>
        <contact_address>Ethics Committee, Building No 2 of Kermanshah University of Medical Sciences, Naft Square, Shahid Beheshti Blvd Kermanshah Kermanshah Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
